[1]
R. R. Palhares, “Efficacy and Safety of Regorafenib in Patients with Characteristics of Good Prognosis in the Treatment of Metastatic Colorectal Cancer: Subgroup Analysis of CORRECT Study”, Rev. Bras. Cancerol., vol. 68, no. 4, p. e–162727, Oct. 2022.